[1] Shum, H.-P., Chan, K.-C., Yan, W.-W., et al. (2012) Regional Citrate Anticoagulation in Predilution Continuous Venovenous Hemofiltration Using Prismocitrate 10/2 Solution. Therapeutic Apheresis and Dialysis, 169, 81-86.
http://www.ncbi.nlm.nih.gov/pubmed/22248200
http://dx.doi.org/10.1111/j.1744-9987.2011.01001.x
[2] Evenepoel, P., Maes, B., anwalleghem, J.V., et al. (2002) Regional Citrate Anticoagulation for Hemodialysis Using a Conventional Calcium-Containing Dialysate. American Journal of Kidney Diseases, 39, 315-323.
http://www.ncbi.nlm.nih.gov/pubmed/11840372
[3] Little, M.A., Conlon, P.J. and Walshe, J.J. (2000) Access Recirculation in Temporary Hemodialysis Catheters as Measured by the Saline Dilution Technique. American Journal of Kidney Diseases, 35, 477-481.
http://www.ncbi.nlm.nih.gov/pubmed/?term=Access+recirculation+in+temporary+
hemodialysis+catheters+as+measured+by+the+saline+dilution+technique
[4] Palsson, R. and Niles, J.L. (1999) Regional Citrate Anticoagulation in Continuous Venovenous Hemofiltration in Critically Ill Patients with a High Risk of Bleeding. Kidney International, 55, 1991-1997.
http://www.ncbi.nlm.nih.gov/pubmed/10231464
http://dx.doi.org/10.1046/j.1523-1755.1999.00444.x
[5] Zheng, Y. and Ding, F. (2015) Application of RCA in CRRT. Chinese Journal of Blood Purification, 1, 47-50.